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Abstract
Background: Leptospirosis is a zoonotic disease infecting a broad range of mammalian hosts, and
is re-emerging globally. California sea lions (Zalophus californianus) have experienced recurrent
outbreaks of leptospirosis since 1970, but it is unknown whether the pathogen persists in the sea
lion population or is introduced repeatedly from external reservoirs.
Methods: We analyzed serum samples collected over an 11-year period from 1344 California sea
lions that stranded alive on the California coast, using the microscopic agglutination test (MAT) for
antibodies to Leptospira interrogans serovar Pomona. We evaluated seroprevalence among yearlings
as a measure of incidence in the population, and characterized antibody persistence times based on
temporal changes in the distribution of titer scores. We conducted multinomial logistic regression
to determine individual risk factors for seropositivity with high and low titers.
Results: The serosurvey revealed cyclical patterns in seroprevalence to L. interrogans serovar
Pomona, with 4–5 year periodicity and peak seroprevalence above 50%. Seroprevalence in yearling
sea lions was an accurate index of exposure among all age classses, and indicated on-going exposure
to leptospires in non-outbreak years. Analysis of titer decay rates showed that some individuals
probably maintain high titers for more than a year following exposure.
Conclusion: This study presents results of an unprecedented long-term serosurveillance program
in marine mammals. Our results suggest that leptospirosis is endemic in California sea lions, but
also causes periodic epidemics of acute disease. The findings call into question the classical
dichotomy between maintenance hosts of leptospirosis, which experience chronic but largely
asymptomatic infections, and accidental hosts, which suffer acute illness or death as a result of
disease spillover from reservoir species.
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Background
Leptospirosis is an acute febrile zoonosis of global impor-
tance, caused by spirochetes of the genus Leptospira [1-5].
Owing to recent epidemics in humans in Nicaragua [6],
Brazil [7], India [8] and South East Asia [9], and rising
incidence in domestic dogs [10,11], leptospirosis has
been identified as an emerging infectious disease [4,12].
Outbreaks in humans are usually seasonal and associated
with flooding or activities involving exposure to contami-
nated water or animal tissues, such as swimming, hunt-
ing, farming, and working in abattoirs or veterinary
settings. Designing public health measures to control lept-
ospirosis requires an understanding of the ecology of the
disease in its many wild and domestic mammalian hosts.
The Leptospira interrogans complex (sensu lato) includes
>200 pathogenic serovars [2], which differ widely in their
interactions with different host species. A central tenet of
the epidemiology of leptospirosis is the distinction
between maintenance hosts and accidental hosts for a
given serovar, or, equivalently, between host-adapted and
non-host-adapted serovars [1-3]. In this framework,
maintenance hosts develop a chronic, largely asympto-
matic infection of their proximal renal tubules, and may
shed leptospires in their urine for months or years. In con-
trast, accidental hosts experience acute infections, with
symptoms ranging from malaise to multi-organ failure
and death.
In California, leptospirosis has resurged in humans and
domestic dogs [13,14]. Disease outbreaks have also
occurred in California sea lions (Zalophus californianus) off
the central and northern coasts of California, with hun-
dreds of animals dying in each outbreak. The first lept-
ospirosis epidemic documented in California sea lions
was in 1970, and Leptospira interrogans serovar Pomona
was isolated from infected sea lions [15,16]. Since then
there have been repeated epidemics, with an outbreak
every three to five years since 1984 [17-19]. The epidemi-
ology of the disease in sea lions is unclear, and the role of
sea lions in maintaining this zoonotic disease is
unknown. Crucially, it is unknown whether the recurring
epidemics of leptospirosis in sea lions result from
repeated introduction of the pathogen from external res-
ervoirs, or from cyclic dynamics of an endemic disease.
Numerous factors can cause epidemics to cycle, including
environmental drivers, changes in host population den-
sity, antigenic changes by the pathogen, or changes in the
proportion of the host population that is immune, associ-
ated with the concept of "herd immunity" [20]. The
premise of herd immunity is that an epidemic cannot
occur if a certain threshold proportion of a population is
immune due to previous infection or vaccination (thus
indirectly protecting susceptible individuals against infec-
tion). As the pool of susceptible individuals is replenished
by birth or immigration, eventually an epidemic becomes
possible again.
As the first step to elucidate the epidemiology of recurring
leptospirosis outbreaks in California sea lions, and to
identify future research directions, this study investigated
changes in seroprevalence in an unusually detailed longi-
tudinal dataset from 1995–2005. In an unvaccinated pop-
ulation, seroprevalence is a measure of past exposure to
leptospirosis. However, the duration of seropositivity fol-
lowing leptospiral infection is not well known for any
host [1,21-23], and is completely unknown for sea lions.
Because this is a crucial quantity for interpretation of sero-
logical time series, we analyzed available data to charac-
terize the decay rate of antibody titers to leptospires.
Methods
Sampling
Serum samples were collected from California sea lions
stranding along the central and northern California coast
(37°42'N, 123°05'W to 35°59'N, 121°30'W) and
archived at The Marine Mammal Center (TMMC) at -
70°C. All animals were sampled during routine veterinary
care while in rehabilitation as authorized by the National
Marine Fisheries Service Research and Enhancement Per-
mit to Take Marine Mammals (# 932-1489-08), and
approved by The Marine Mammal Center's Internal Ani-
mal Care and Use Committee. For each sex and age class,
20 samples for each year were randomly selected from the
archive; when fewer than 20 samples were available for a
given sex/age class and year, all samples were used (Table
1). Animals were classified as having stranded because of
leptospirosis if serum chemistry results were indicative of
leptospirosis (blood urea nitrogen > 100 mg/dl, creatinine
> 2 mg/dl, sodium > 155 meq/L and phosphorus > cal-
cium) or if gross necropsy (swollen kidneys with loss of
renule differentiation and pale tan renule cortices) and
histopathology (interstitial nephritis) revealed renal dis-
ease consistent with leptospirosis [19]. To reduce poten-
tial bias arising from sampling only stranded sea lions, a
reduced dataset was generated which excluded leptospiro-
sis-induced strands.
Further serum samples from stranded California sea lions
were obtained from two other stranding centers in Cali-
fornia, SeaWorld in San Diego, CA (collection range
33°45'N, 118°07'W to 32°32'N, 117°07'W) and the
Marine Mammal Care Center at Fort Macarthur, CA (col-
lection range 34°17'N, 119°30'W to 33°45'N,
118°07'W). All available samples were analyzed (Table
2).
Serology
Serum samples were submitted to the California Animal
Health and Food Safety Laboratory (Davis, CA), andBMC Infectious Diseases 2007, 7:125 http://www.biomedcentral.com/1471-2334/7/125
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assayed for Leptospira antibodies using the microscopic
agglutination test (MAT) [24-26]. The endpoint reading of
the microagglutination reaction was reported as the serum
dilution at which 50% of the leptospires were aggluti-
nated by direct observation using inverted field micros-
copy. Leptospira cultures and serovar-specific control sera
were obtained from the USDA National Veterinary Serv-
ices Laboratories (Ames, Iowa). A previous study evalu-
ated the MAT for sera from California sea lions and
reported 100% sensitivity at ≥ 1:3200 based on 19 posi-
tive controls (established by clinical signs of disease,
lesions at necropsy, and visible leptospires in silver
stained kidney sections) and 100% specificity at <1:100
based on 19 negative controls (captive-bred animals that
had never exhibited signs of renal disease) [27].
Of the 1344 samples of the 1995–2005 time series, 724
were diluted to a maximum dilution of 1:204800, 17 to a
maximum dilution of 1:3200, and 553 to a maximum of
1:800. 50 samples were removed from the analysis due to
contamination or incomplete data. The serum samples
were assayed against six Leptospira serovars, representing
the serovars of diagnostic interest in California during the
study period: L. interrogans serovar Pomona, L. interro-
gans serovar Bratislava, L. kirschneri serovar Grippoty-
phosa, L. interrogans serogroup Icterohaemorrhagiae
serovar Copenhageni, L. interrogans serovar Canicola,
and L. interrogans serovar Hardjo type Hardjoprajitno.
Most analyses reported here are based on the titer to sero-
var Pomona, which has been the serovar of all Leptospira
isolates from wild California sea lions [15,18,28]. Sam-
ples that agglutinated at the 1:100 dilution were classified
as seropositive [2,27], and we further distinguished
between high-titer seropositives that agglutinated at dilu-
tions of 1:800 or higher [23] and low-titer seropositives
that agglutinated only at dilutions below 1:800.
Analysis
Graphical and statistical analyses were conducted using
Matlab v6.1 (The Mathworks, Cambridge MA) and R [29].
Seroprevalences were calculated as binomial proportions
with exact confidence intervals [30]. To determine indi-
vidual risk factors, multinomial logistic regression [31,32]
was conducted treating the serologic result (negative,
Table 1: Sample sizes for TMMC seroprevalence time series, by sex and age. Total numbers and numbers excluding leptospirosis-
induced strands (in parentheses) are shown
Sex Age 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
F e m a l e Y e a r l i n g 8 1 61 92 3 8 1 82 11 93 82 02 9
(1–2 y.o.)a (3) (14) (17) (22) (7) (11) (20) (18) (38) (9) (29)
Subadult 9 6 19 23 11 19 16 12 20 13 5
(2–5 y.o.) (3) (5) (13) (19) (2) (13) (11) (10) (16) (7) (5)
A d u l t 9 7 2 31 91 82 02 01 82 01 92 0
(≥ 5 y.o.) (5) (5) (16) (16) (13) (19) (18) (17) (20) (16) (19)
M a l eY e a r l i n g 1 21 81 91 81 71 71 82 03 81 83 6
(1–2 y.o.)a (9) (18) (15) (18) (10) (12) (18) (18) (38) (6) (33)
Juvenile 21 25 20 20 20 20 19 20 20 19 16
(2–4 y.o.) (2) (16) (12) (19) (3) (5) (8) (9) (12) (2) (11)
Subadult 19 14 15 20 20 19 13 10 10 19 19
(4–8 y.o.) (3) (10) (9) (14) (4) (8) (10) (6) (9) (9) (9)
A d u l t 1 28 9 4 5 81 49 81 76
(≥ 8 y.o.) (7) (8) (7) (3) (4) (7) (12) (6) (8) (9) (6)
Total 90 94 124 127 99 121 121 108 154 125 131
(32) (76) (89) (111) (43) (75) (97) (84) (141) (58) (112)
a The yearling class may include some pups 8–12 months of age, stranding in February to May.
Table 2: Sample sizes for SeaWorld and Marine Mammal Care Center
Source Subset 2000 2001 2002 2003 2004 2005
SeaWorld Total 4 17 15 58 38 49
Yearling 0 4 1 17 14 30
MMCC Total 0 0 0 0 14 30
Y e a r l i n g 00004 1 2BMC Infectious Diseases 2007, 7:125 http://www.biomedcentral.com/1471-2334/7/125
Page 4 of 11
(page number not for citation purposes)
high-titer, low-titer) as a nominal outcome with the fol-
lowing covariates: age, sex, outbreak year (1995,1999,
2000,2004) versus non-outbreak year, and season
(August-December versus January-July). These seasonal
ranges were chosen to minimize the residual deviance of
the regression. Outcomes of the multinomial logistic
regression are assessed in terms of relative risk ratios
(RRR), which describe the ratio between the relative risk
of a given outcome versus a reference outcome (e.g. high-
titer seropositivity versus seronegativity) for one factor
compared to another (e.g. for male versus female individ-
uals). Antibody half-life was estimated as the reciprocal of
the slope of the number of two-fold decreases in titer ver-
sus time. Throughout the study, proportions were com-
pared using a chi-squared test with continuity correction,
or Fisher's exact test when the expected number in any cat-
egory was <5 [33]. All statistical tests were two-tailed.
Yearling seroprevalence was assessed as an index of lept-
ospirosis exposure by testing for linear relationship with
the relative change (i.e. ratio of successive values) in high-
titer seroprevalence for the whole population. (The mean
of two seroprevalence estimates, derived from the full
dataset and from the reduced dataset without leptospiro-
sis strandings, was taken to be the most unbiased estimate
of population seroprevalence; qualitatively similar results
were obtained using either estimate on its own.) Possible
non-linear effects were tested by performing a regression
with a quadratic term, and normality of the residuals was
assessed using a Kolmogorov-Smirnov test. The intercept
of the linear regression, b, gives the relative change in
high-titer seroprevalence when yearling seroprevalence is
zero. If zero yearling seroprevalence indicates no new
exposure for the population, then we can calculate the
annual per capita probability that antibody decay will
cause loss of high-titer status, pdecay. Let NHT and N be the
number of high-titer individuals and total population
size, respectively, such that high-titer seroprevalence is
NHT/N. Let pdeath be the annual per capita probability of
death, and λ be the annual growth rate of the population
such that N(t) = λN(t - 1). If death and antibody decay are
independent processes, and there is no new exposure in
year t, then NHT (t) = (1 - pdeath)(1 - pdecay)NHT (t - 1). If new
recruits to the population are seronegative, as observed for
sea lion pups [27], then:
and therefore
pdecay = 1 - bλ/(1 - pdeath). (1)
Given approximate values pdeath = 0.07 and λ = 1.05 [34],
pdecay ≈ 1–1.13b.
Results
Comparison of serovars
To determine the dominant serovar(s) in this dataset, we
tabulated which serovar(s) contributed the maximum
titer score for each sample with one or more titer ≥ 1:800
(Table 3). Of 449 samples with at least one titer ≥ 1:800,
serovar Pomona was the unique maximum for 201 (45%)
samples and was positive at the highest dilution measured
for an additional 226 (50%) samples. In only 19 of 449
(4%) samples did another serovar have a higher titer than
serovar Pomona. Qualitatively similar results were found
for all samples with one or more titers ≥ 1:100. Because of
the consistently higher titer scores for serovar Pomona,
combined with the fact that all Leptospira isolates from
wild California sea lions have been serovar Pomona
[15,18,28], we restrict the remainder of our analysis to
serovar Pomona and attribute the positive titers to other
serovars to the known cross-reactivity of the MAT [10,35].
Seroprevalence time series, 1995–2005
Seroprevalence of leptospiral antibodies in 1338 stranded
California sea lions exhibited cycles of 4–5 year periodic-
ity over the duration of the study (Figure 1a). Peaks in
seroprevalence corresponded to reported outbreaks of
leptospirosis in 1995, 1999, 2000, and 2004. Cycles were
b
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Table 3: Summary of serovars corresponding to maximum titer scores for all samples with at least one titer ≥ 1:800
Serovar Pomona Bratislava Canicola Grippo. Hardjo Ictero. Total samples
Unique maximuma 201 9 3 2 2 1 218
Shared maximum (detection limit)b 226 212 100 114 79 132 226
Shared maximum (below limit)c 330 2 1 2 5
Titer ≥ 1:800d 435 391 221 271 217 302 449
a Samples for which only one serovar had the maximum score.
b Samples for which two or more serovars shared the maximum score, which was the highest dilution measured for that sample.
c Samples for which two or more serovars shared the maximum score, at a titer below the highest dilution measured for that sample.
d Number of samples with titers ≥ 1:800 for each serovar.BMC Infectious Diseases 2007, 7:125 http://www.biomedcentral.com/1471-2334/7/125
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most evident in seroprevalence estimates derived from all
stranded sea lions (solid lines); when leptospirosis-
induced strands were removed from the analysis (dashed
lines), the cyclic pattern remained but the 2004 peak was
greatly reduced. The cyclic variation arose in the preva-
lence of high antibody titers (≥ 1:800) reflective of recent
exposure, while the proportion of individuals with lower
positive titers was constant within uncertainties (Figure
1b,c).
High-titer seroprevalence remains at 10–30% in non-out-
break years, possibly indicating on-going transmission of
leptospirosis. We explored the use of yearling seropreva-
lence as an index of incidence of leptospirosis in a given
year. Sea lion pups remain on the rookery islands for
roughly one year after birth [36] and do not appear to be
exposed on the rookeries (unpublished data), so yearlings
are in their first year of possible exposure to leptospirosis.
Yearling seroprevalence exhibited strong peaks in out-
break years, but in intervening years dropped to lower lev-
els than the population seroprevalence (Figure 2a).
Seropositive yearlings were observed in all years except
1996 (0/33, 95% CI for binomial proportion: 0–0.11),
indicating that exposure to L. interrogans serovar Pomona
continued at low levels between outbreaks. Yearling sero-
prevalence was strongly correlated with exposure levels
for all ages, as measured by the relative year-to-year
change in high-titer seroprevalence (y = 0.28 + 4.3x, R2 =
0.80; Figure 2b). (When the dependent variable was based
on seroprevalence estimates with yearlings excluded to
avoid possible circularity, the correlation was even
stronger (R2 = 0.88), but the whole-population results are
shown because they inform our work on antibody decay,
below.) In 2000, the overall increase in seroprevalence
was small compared to a yearling seroprevalence >50%,
because of a large number of strandings caused by domoic
acid toxicity in that year, which diluted the influence of
animals stranding because of leptospirosis [19]. When the
point for year 2000 was excluded as an outlier, the linear
relationship was much stronger (y = 0.17 + 5.7x, R2 = 0.98;
Figure 2b). For both regressions, a quadratic term was not
supported and residuals did not deviate significantly from
normality.
Individual risk factors and asymptomatic seropositives
Multinomial logistic regression was performed to assess
individual risk factors for high-titer and low-titer seropos-
itivity (Table 4). The relative risk of high titer versus seron-
egativity was 7.0 times higher in outbreak years than in
non-outbreak years, and 4.9 times higher during the
August-December season when most leptospirosis strands
are reported. The relative risk of high titers was 4.1-fold
higher for males than for females. The relative risk of high
titers is highest for juveniles and subadults, and drops
Cycles in seroprevalence to L. interrogans serovar Pomona in California sea lions stranding in northern California Figure 1
Cycles in seroprevalence to L. interrogans serovar Pomona in California sea lions stranding in northern Califor-
nia. Three panels correspond to (a) total seroprevalence (titers ≥ 1:100), (b) low-titer seroprevalence (titers ≥ 1:100 and 
<1:800), and (c) high-titer seroprevalence (titers ≥ 1:800). Solid lines show estimates derived from a random sample of all 
stranded sea lions, including those judged to have stranded due to leptospirosis. Dashed lines show estimated seroprevalence 
after leptospirosis strands are removed from the dataset. Isolated points in 1992 and 1993 show estimates derived from non-
randomized samples from an earlier publication (18). Error bars show 95% confidence intervals.
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sharply for adults. Note that the juvenile class contains
only males (Table 1), so the sex effect may account for
some of the elevated risk for the juvenile class. The relative
risk of low titers versus seronegativity was not influenced
by outbreak years (p = 0.31) or season (p = 0.60). In sharp
contrast to high-titer results, the relative risk of low posi-
tive titers increases steadily with age, with subadults and
adults respectively at 24-fold and 44-fold higher risk than
yearlings to have low titers.
Of 514 sea lions with positive titers, 200 stranded for rea-
sons other than leptospirosis; we called these individuals
asymptomatic seropositives. The proportion of asympto-
matic seropositives was higher among low-titer individu-
als than high-titer individuals (72/79 versus 128/435, p <
0.001). This pattern held for males and females analyzed
independently (p < 0.001 in each case). The asymptomatic
proportion showed a weak tendency to be higher in
females than males (p = 0.13). A greater proportion of
seropositive individuals were asymptomatic in non-out-
break years than outbreak years (p < 0.001). The asympto-
matic proportion was higher among adults than younger
age classes (p < 0.001); this pattern held for high titers (p
< 0.001) but not for low titers (p = 0.73). Of the 200
asymptomatic seropositives, 30 stranded due to domoic
acid toxicity, 40 due to malnutrition, and the remaining
130 due to varied causes including trauma, cancer, behav-
ioral problems and unrecorded causes; we cannot exclude
the possibility that some of these animals stranded due to
subclinical leptospirosis.
Antibody decay and loss of seropositivity
Yearling seroprevalence in non-outbreak years was lower
than overall seroprevalence. If yearling seroprevalence is
an accurate index of transmission within a year (Figure
2b), then this difference indicates that some older individ-
uals maintain seropositivity for one or more years follow-
ing exposure. The y-intercepts of the regression lines in
Figure 2b provide estimates of the proportion of individ-
uals that maintain a high titer from one year to the next
without being re-exposed, or conversely the proportion
pdecay  that lose their high titer. When corrections are
applied for deaths and recruitment of new unexposed
pups (Equation 1), this proportion is estimated to be pdecay
= 0.69 (95% CI 0.06–1) for the full dataset, or pdecay = 0.81
(95% CI 0.59–1) when the 2000 point is excluded. Inter-
preting these values requires consideration of the quanti-
tative distribution of titer scores. After stimulation by the
antigen has ceased, circulating antibodies are convention-
ally thought to decay exponentially, with half-life of IgG
estimated as 23–25 days [37]. Because titers are scored by
two-fold dilutions, a drop in titer on a log2 scale corre-
sponds to the intervening number of half-lives. Of 248
seropositive samples assayed to dilutions up to 1:204800,
208 were high-titer (≥ 1:800) and 142 were positive at the
maximum dilution so their precise titer is unknown (Fig-
ure 3a). The remaining 66/208 (32%) of high-titer scores
are between 1 and 8 two-fold dilutions from the 1:800
Yearling seroprevalence and relation to exposure Figure 2
Yearling seroprevalence and relation to exposure. (a) 
Time series of estimated yearling seroprevalence, estimated 
as in Figure 1. (b) Linear regression of the relative change in 
high-titer seroprevalence for the whole population against 
yearling seroprevalence. Squares show data points for partic-
ular years (labeled by the final two digits of the calendar year 
t). The dashed line shows the regression including all points; 
the dotted line shows the regression with the point for the 
year 2000 excluded.
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threshold for high titers, so the high titer would be lost
after 1–8 half-lives with no re-exposure. However, 142/
208 (68%) of high-titer scores are "off the charts", so we
cannot assess how many half-lives they are from the
threshold. We can conclude only that the titer distribu-
tions predict that ≥ 32% of high-titer individuals should
drop to low-titer or become seronegative after 8 half-lives
without exposure. This is consistent with the regression
estimates of 69% and 81%, but does not test the precise
values.
Antibody decay is evident in titer distributions during
periods of low exposure. Titers from non-outbreak years
showed more intermediate values and fewer maximum
values than titers from outbreak years (Figure 3b). When
stratified by season, titer distributions were heavily
skewed toward the highest values during the leptospirosis
outbreak seasons of July-September and October-Decem-
ber, then declined progressively to lower values in Janu-
ary-March and April-June (Figure 3c). These patterns
cannot be analyzed quantitatively because of seasonal dif-
ferences in stranding rates across age classes, but the same
qualitative patterns arose when yearling or adult samples
were excluded from the analysis.
Direct estimates of titer decay rates could be made from
six paired serum samples available from California sea
lions undergoing rehabilitation following infection.
Because the second sample in each instance was seroneg-
ative (and we did not know when the detection threshold
was crossed), only a minimum bound on decay rate could
be estimated from these data. The boundary of the allow-
able region for decay rates is defined by the best-fit line
through the origin and the three fastest-decaying points,
which had slope 0.050 (95% CI 0.046,0.054; R2 = 0.92)
corresponding to a half-life of 20 (19–22) days.
Comparison with animals stranded in southern California
We compared the seroprevalence of sea lions sampled in
southern California to the TMMC time series (Figure 4).
The 2000 outbreak was reflected in the high-titer seroprev-
alence from SeaWorld (though sample size was only n =
4). The 2004 outbreak was not evident at either southern
California site: high-titer seroprevalence was greater at
TMMC than MMCC (p  = 0.002) and SeaWorld (p  <
0.001), as was yearling seroprevalence (p = 0.047 and p <
0.001, respectively).
Discussion
Leptospirosis in California sea lions does not fit neatly
into the classical dichotomous framework wherein a given
host species is either a maintenance host or an accidental
host for a particular serovar of pathogenic Leptospira. In
sea lions the disease exhibits characteristics of accidental
hosts, with pathogenic and sometimes fatal outcomes for
individual animals and dramatic outbreaks at the popula-
tion scale. Yet the disease also appears to circulate at low
levels between outbreaks, and asymptomatic seropositiv-
ity (even with high titers) is common among adults.
Other investigators have reported chronic shedding of
leptospires, another characteristic of classical mainte-
nance hosts, with one sea lion reported to shed for at least
154 days following infection [17].
All available evidence, including several isolates from wild
sea lions [15,18,28] and comparison of MAT titer scores
(Table 3), points to L. interrogans serovar Pomona as the
cause of leptospirosis in this population. Mixing of host-
adapted and non-adapted traits may be a property of sero-
var Pomona, which causes disease in pigs, cattle and
horses, but can also be shed for 4–6 months by those spe-
cies [38-40]. Of course, the possibility that other serovars
are circulating cannot be excluded without intensive
Table 4: Risk factors for high-titer (≥ 1:800) and low-titer (≥ 1:100 and <1:800) seropositivity to L. interrogans serovar Pomona. 
Significant variables in the multinomial logistic regression model and corresponding relative risk ratios (RRR) are shown.a
High titer seropositivity vs seronegativity Low titer seropositivity vs seronegativity
Variable Value Nb RRR 95% CI p-value RRR 95% CI p-value
Age Yearling 450 (383) 1 1
Juvenilec 220 (99) 4.41 (2.80,6.95) <0.001 5.99 (1.5,23.9) 0.011
Subadult 331 (195) 3.79 (2.54,5.67) <0.001 23.8 (6.85,82.6) <0.001
Adult 293 (241) 0.79 (0.49,1.27) 0.32 43.6 (12.9,147.4) <0.001
Sex Female 565 (456) 1 1
Male 729 (462) 4.13 (2.89,5.89) <0.001 8.29 (4.62,14.9) <0.001
Season Jan-Jul 629 (549) 1 1
Aug-Dec 665 (369) 4.87 (3.53,6.72) <0.001 1.15 (0.68,1.92) 0.60
Outbreak year No 859 (710) 1 1
Yes 435 (208) 6.97 (5.02,9.68) <0.001 1.35 (0.76,2.39) 0.31
a Model had residual deviance 1483.3 on 1287 df (chi-squared p = 1; Nagelkerke R2 = 0.51).
b Sample size in each group is shown as a total number and as a number excluding leptospirosis-induced strands (in parentheses).
c Note that the juvenile age class contains only males.BMC Infectious Diseases 2007, 7:125 http://www.biomedcentral.com/1471-2334/7/125
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efforts to isolate and identify further leptospires from wild
sea lions. Two serovars that were not included in our MAT
panel warrant special mention.L. interrogans serovar
Autumnalis is increasingly reported in serological studies
of dogs in the United States [11] and is known to cross-
react with Pomona in the MAT [11,41]. L. kirschneri sero-
var Cynopteri has been detected serologically in a geo-
graphically separated population of Z. californianus in the
Gulf of California [42], but the highest titer observed
(1:50) was below our threshold for seropositivity. On-
going circulation of serovar Pomona remains the most
parsimonious explanation for the available data.
If the classical maintenance/accidental-host model of
leptospirosis epidemiology is overly simplified, then pub-
lic health officials must broaden their view of potential
reservoirs for this zoonotic pathogen. If the California sea
lion population is indeed a reservoir for serovar Pomona,
then health warnings regarding leptospirosis risk from
stranded sea lions should be extended to non-outbreak
periods. The possibility that on-going exposure of sea
lions to serovar Pomona arises from continuous contact
with an unidentified external reservoir cannot be
excluded, but this explanation would only broaden the
public health implication to include other host species.
The present study identifies clear cycles of 4–5 year perio-
dicity in seroprevalence to L. interrogans serovar Pomona
in the California sea lion population off the California
coast. The cyclic pattern arises from changes in the preva-
lence of high titer scores reflective of recent exposure, and
peak years of the cycle correspond to observed peaks in
sea lions stranding with leptospirosis. Seroprevalence in
yearling sea lions is strongly correlated with annual
changes in high-titer seroprevalence for the whole popu-
lation, and indicates on-going exposure to serovar
Pomona between outbreak years; this finding is consistent
with earlier studies reporting continued stranding and
death due to leptospirosis in non-outbreak years [18,19],
and inconsistent with expected patterns for an accidental
host. Evaluation of individual risk factors reveals that
juvenile and subadult animals are at greatest risk for high-
titer seropositivity, while adults are at sharply reduced
risk.
These observations suggest strongly that leptospirosis is
endemic within the sea lion population, and raise the
intriguing possibility that repeated epidemics arise from
the intrinsic interaction of birth rates and herd immunity,
rather than the environmental drivers that are commonly
postulated. Younger animals get infected in outbreak
years, acquiring high titers that may persist for a year or
more, while most adults are immune from previous expo-
sure. The pathogen may persist through off-seasons and
non-outbreak years via chronic infections and a low level
Distributions of MAT scores from the 1995–2005 time series Figure 3
Distributions of MAT scores from the 1995–2005 
time series. Part (a) shows the histogram of all 248 positive 
titers among the 724 samples that were measured to a maxi-
mum dilution of 1:204800. Parts (b) and (c) show distribu-
tions of different subdivisions of these 248 scores, 
represented as cumulative distribution functions that show 
the proportion of samples with scores less than or equal to a 
given value. Titer scores are represented as log2(MAT/100), 
such that a score of 0 corresponds to a titer of 1:100, a score 
of 1 to a titer of 1:200, etc. The highest score of 11 corre-
sponds to titers ≥ 1:204800. Sample sizes for (c) are Jan-Mar 
(N = 21), Apr-Jun (N = 21), Jul-Sep (N = 115) and Oct-Dec 
(N = 91).
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of on-going transmission, possibly associated with the
increased prevalence of asymptomatic seropositivity and
low titers during these periods. We emphasize, though,
that present data cannot exclude the possibility of on-
going contact with another reservoir species. Mathemati-
cal models integrating the dynamics of disease transmis-
sion and immunity with sea lion demographics,
combined with further data collection, are essential to
clarify this issue.
Live-stranded marine mammals are a biased sample of the
wild population, over-representing sick and weak individ-
uals, so seroprevalence in stranded individuals may
exceed the true population value. We addressed this bias
by providing alternate seroprevalence estimates based on
a reduced dataset excluding clinical leptospirosis cases,
but this approach may yield underestimates during out-
breaks if a substantial proportion of infected animals do
not come ashore. Of over 200,000 sea lions breeding off
the California coast [34], just a few hundred leptospirosis
cases strand and are admitted to rehabilitation during a
typical outbreak year [19]. Given peak seroprevalence esti-
mates >50%, it appears that many infected animals do not
strand. Serosurveillance of free-ranging sea lions is crucial
to determine how the patterns reported here scale to the
population level.
Data from sea lions stranded in southern California
showed a general trend of lower seroprevalence than was
found in central and northern California, and, intrigu-
ingly, there is no evidence of the 2004 outbreak in data
from the southern range. All California sea lions in the
eastern Pacific Ocean breed on rookery islands off the
coast of southern California and the Baja peninsula, so
animals stranding in different regions of California are
thought to be drawn from a single population. Lept-
ospirosis strandings (and high-titer seropositivity) peak
during July to November [19], when sea lions migrate
northward following the breeding season to forage off
central and northern California, or points further north. It
is unknown whether this timing is coincidental or lept-
ospirosis transmission (or exposure) is aided by environ-
mental factors in the northern range. Male sea lions
migrate further north than females, and in greater num-
bers, while breeding females remain closer to the rooker-
ies to nurse pups. This difference in migratory behavior
Seroprevalence in stranded California sea lions: other datasets Figure 4
Seroprevalence in stranded California sea lions: other datasets. High-titer and yearling seroprevalence from other 
stranding ranges in southern California. For comparison, estimates from the 1995–2005 time series are shown in gray (full 
dataset, including leptospirosis-induced strands). Solid lines and squares show estimates from SeaWorld (San Diego CA), while 
dashed lines and triangles show estimates from the Marine Mammal Care Center (Fort Macarthur CA).
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may play a role in the observed sex difference in lept-
ospirosis incidence, although similar sex differences have
been observed in other species including humans and are
not easily explained [13,43]. Data presented here suggest
that leptospirosis incidence is lower among animals
remaining in southern California, but increased sampling
of stranded and wild-caught individuals is needed to con-
firm this pattern.
The predominance of high titers among seropositive sea
lions (also reported by Colagross-Schouten [27]) indi-
cates that most animals had been exposed recently before
stranding. Yet the time course of titer decay for this host-
serovar interaction is unknown, so we assembled evidence
to assess the duration of high MAT titers in sea lions. Pop-
ulation-level changes in seroprevalence suggest that
approximately 69% of high-titer individuals lose their
high titer in a year without re-exposure to the pathogen
(but note the broad 95% CI, 0.06–100%). This is consist-
ent with observed titer distributions in sea lions, which
indicate that ≥ 32% of individuals should lose their high
titers after 8 antibody half-lives, but more precise predic-
tions cannot be derived from titer distributions because
the majority of sea lion titers were positive at the highest
dilution measured. Maintenance of high MAT titers for
several years is not reported in experimental infection
studies, which rarely last that long, but has been reported
for humans following severe infections [1,21-23]. MAT
titer half-life for sea lions in rehabilitation was estimated
crudely to have upper bound 20 (19–22) days, lower than
the conventional half-life of 23–25 days for IgG antibod-
ies. While this difference could be attributed to numerous
factors, including that MAT titers reflect both IgM and IgG
levels [1] and antibiotic therapy may reduce titer duration
[35], it is important to note the small sample size under-
lying the estimate, and the well-established finding that
human MAT decay rates vary substantially [21-23]. Titer
distributions in stranded sea lions are qualitatively con-
sistent with gradual antibody decay following exposure,
but intermediate titers (from 1:3200 to 1:51200) appear
less commonly than a simple exponential decay model
would predict. Longitudinal titers from individuals recov-
ering from acute infection are required to characterize the
true rate of antibody decay from high levels. The possible
role of chronic shedders, in maintaining their own low-
titer seropositivity and in boosting the antibody responses
of others, requires investigation.
Conclusion
This study presents results of an unprecedented serosur-
veillance program in marine mammals, tracking seroprev-
alence to L. interrogans serovar Pomona in 1344 stranded
California sea lions over 11 years. The data show cycles of
4–5 year periodicity, with peaks corresponding to
observed increases in sea lion strandings due to lept-
ospirosis. Seroprevalence in yearling sea lions is an accu-
rate indicator of incidence of leptospiral infection for all
age classes, and indicates on-going exposure to serovar
Pomona between outbreak years. These results suggest
that sea lions occupy a middle ground between classically-
defined maintenance and accidental hosts of leptospiro-
sis, but many questions remain. Further data are needed
to address crucial uncertainties such as the seroprevalence
of the free-ranging population, the prevalence of chronic
shedding among sea lions, and the spatiotemporal inter-
action of sea lion migration and leptospirosis risk. Molec-
ular comparisons of L. interrogans isolates from sea lions
and possible external reservoirs would contribute vital
evidence regarding the question of endemic persistence
versus repeated introductions. Further analysis of existing
data is also essential, particularly via mathematical mod-
els that integrate the dynamics of disease transmission,
population growth, and antibody decay with all available
data types. The sea lion/leptospirosis system raises ques-
tions regarding the accepted view of the epidemiology of
this important zoonosis, but only through a sustained
interdisciplinary effort will definitive answers be
obtained.
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